We are live on
!
Find out more
MSS
Mitchell Sinkler & Starr Portfolio holdings
AUM
$240M
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+0.08%
1 Year Est. Return
+24.63%
3 Year Est. Return
+72.22%
5 Year Est. Return
+87.27%
10 Year Est. Return
+266.58%
AUM
$456M
AUM Growth
–
Cap. Flow
+$464M
Cap. Flow
% of AUM
101.68%
Top 10 Holdings %
Top 10 Hldgs %
37.08%
Holding
153
New
153
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$26.7M |
| 2 |
ExxonMobil
XOM
|
+$26.2M |
| 3 |
Merck
MRK
|
+$23.3M |
| 4 |
Procter & Gamble
PG
|
+$22.4M |
| 5 |
GE Aerospace
GE
|
+$14.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.13% |
| 2 | Consumer Staples | 16.65% |
| 3 | Energy | 14.82% |
| 4 | Industrials | 12.86% |
| 5 | Technology | 5.46% |
Similar funds
HIP
QFW
GBL
RTL
CIA
IIM
AP
SP
Mitchell Sinkler & Starr's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Mitchell Sinkler & Starr, which disclosed 153 positions worth $456M. Its ten largest holdings account for 37% of the portfolio.
Its largest position is Johnson & Johnson: 315,040 shares worth $27M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Energy.
- Mitchell Sinkler & Starr's largest Q2 2013 buy was Johnson & Johnson: 315,040 shares worth $27M.
- Mitchell Sinkler & Starr's ten largest holdings make up 37% of its $456M portfolio in Q2 2013.
- Mitchell Sinkler & Starr disclosed 153 positions in Q2 2013, its first 13F filing on record.
Based on Mitchell Sinkler & Starr's 13F filing for Q2 2013, filed 24 Jul 2013.